Novozymes A/S
NVZMY | OTC
$69.21
+$0.14 (+0.21%)
Nov 2, 2026, 1:24 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 326.24 | 608.51 | 33.50 | 197.70 | 353.42 | 34.71 |
PEG Ratio | 3.77 | -6.48 | 0.07 | 11.56 | -4.16 | -3.88 |
PS Ratio | 40.69 | 48.71 | 5.68 | 41.32 | 74.27 | 6.99 |
PB Ratio | 15.57 | 16.69 | 7.27 | 7.04 | 12.62 | 8.73 |
P/FCF Ratio | 225.20 | 282.64 | 48.48 | 87.23 | 52.91 | 28.70 |
P/OCF Ratio | 138.40 | 182.93 | 24.47 | 24.30 | 36.75 | 22.51 |
OCF/S Ratio | 29.40 | 26.63 | 23.20 | 170.05 | 202.06 | 31.08 |
Debt / Equity Ratio | 2.07 | 0.16 | 0.56 | 0.50 | 0.04 | 0.43 |
Quick Ratio | 0.44 | 1.06 | 0.80 | 0.78 | 0.85 | 1.09 |
Current Ratio | 0.72 | 1.73 | 1.30 | 1.33 | 1.38 | 1.66 |
Asset Turnover | 0.25 | 0.25 | 0.63 | 0.08 | 0.08 | 0.68 |
Interest Coverage | 10.96 | 7.52 | 20.41 | 3.93 | 7.48 | 38.85 |
Return on Equity | 5.37% | 2.73% | 21.64% | 3.57% | 3.58% | 25.15% |
Return on Assets | 3.57% | 2.01% | 10.65% | 1.76% | 1.71% | 13.77% |
Return on Invested Capital | 2.63% | 3.36% | 14.53% | 2.09% | 2.02% | 16.66% |
Dividend Yield | 0.24% | 0.13% | 2.81% | 1.57% | 0.98% | 1.51% |
Payout Ratio | 69.06% | 81.75% | 94.44% | 309.10% | 346.57% | 52.50% |
FCF Payout Ratio | 55.14% | 37.84% | 137.59% | 138.77% | 54.08% | 43.52% |
Gross Profit Margin | 53.91% | 47.20% | 54.32% | 54.56% | 57.68% | 56.04% |
Net Profit Margin | 14.04% | 7.98% | 16.90% | 20.94% | 21.04% | 20.16% |
Pretax Profit Margin | 17.88% | 10.88% | 21.84% | 25.96% | 26.25% | 25.13% |
Operating Profit Margin | 21.23% | 17.19% | 25.43% | 26.37% | 26.80% | 26.06% |
FCF Margin | 18.07% | 17.23% | 11.71% | 47.37% | 140.38% | 24.37% |
EBITDA Margin | 33.35% | 27.07% | 30.56% | 34.84% | 95.28% | 34.61% |
Add to Watchlist
Select watchlists to add or remove NVZMY